Does Ertapenem Alter the Susceptibility of Pseudomonas aeruginosa to Carbapenems
作者： B. Beović , S. Kreft , K. Seme , M. Čižman
DOI: 10.1179/JOC.2011.23.4.216
关键词:
摘要: Abstract We investigated the effect of ertapenem on carbapenem susceptibility Pseudomonas aeruginosa. Antibiotic consumption was recorded monthly in defined daily doses (DDD)/100 patient-days infectious diseases (ID), abdominal surgery (AS), and surgical intensive care units(SICU) a teaching hospital from January 2005 to December 2008. Trends decreased P. aeruginosa were observed all three units. After introduction ertapenem, number isolates/1000 patients-days per month increased AS SICU (p = 0.05). The increase non-susceptible same units less significant 0.07 p 0.054). Correlations between non-susceptibility for lagtime 1 6 months ahead gave no result. In SICU, 30% variability could be predicted by ertapenem. There is evidence that alters a...
sci-hub.se 参考文章(8)
M. J. DiNubile, I. Friedland, C. Y. Chan, M. R. Motyl, H. Giezek, M. Shivaprakash, R. A. Weinstein, J. P. Quinn, Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 24, pp. 443- 449 ,(2005) , 10.1007/S10096-005-1356-0
Debra A. Goff, Julie E. Mangino, Ertapenem: no effect on aerobic gram-negative susceptibilities to imipenem. Journal of Infection. ,vol. 57, pp. 123- 127 ,(2008) , 10.1016/J.JINF.2008.06.001
P. M. Shah, Ertapenem, the first of a new group of carbapenems. Journal of Antimicrobial Chemotherapy. ,vol. 52, pp. 538- 542 ,(2003) , 10.1093/JAC/DKG404
D. M. Livermore, Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare? Clinical Infectious Diseases. ,vol. 34, pp. 634- 640 ,(2002) , 10.1086/338782
David M. Livermore, Shazad Mushtaq, Marina Warner, Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenems Journal of Antimicrobial Chemotherapy. ,vol. 55, pp. 306- 311 ,(2005) , 10.1093/JAC/DKI009
Amy L. Pakyz, Michael Oinonen, Ronald E. Polk, Relationship of Carbapenem Restriction in 22 University Teaching Hospitals to Carbapenem Use and Carbapenem-Resistant Pseudomonas aeruginosa Antimicrobial Agents and Chemotherapy. ,vol. 53, pp. 1983- 1986 ,(2009) , 10.1128/AAC.01535-08
Archie Clements, Kate Halton, Nicholas Graves, Anthony Pettitt, Anthony Morton, David Looke, Michael Whitby, Overcrowding and understaffing in modern health-care systems: key determinants in meticillin-resistant Staphylococcus aureus transmission Lancet Infectious Diseases. ,vol. 8, pp. 427- 434 ,(2008) , 10.1016/S1473-3099(08)70151-8
Ellie J. C. Goldstein, Diane M. Citron, Victoria Peraino, Tanya Elgourt, Anne R. Meibohm, Shuang Lu, Introduction of Ertapenem into a Hospital Formulary: Effect on Antimicrobial Usage and Improved In Vitro Susceptibility of Pseudomonas aeruginosa Antimicrobial Agents and Chemotherapy. ,vol. 53, pp. 5122- 5126 ,(2009) , 10.1128/AAC.00064-09